transfusion guidelines

(redirected from Active bleeding)

transfusion guidelines

Transfusion medicine Guidlelines for use of blood components, which are usually written in a hospital's policy manual. See Transfusion criteria, Transfusion medicine.
Transfusion guidelines, general criteria
Hemoglobin
 < 8g/dL if healthy and stable
 < 11g/dL if Pt is at risk of ischemia
Acute blood loss ≥ 15% (est) blood volume, tachycardia, oliguria
Symptomatic anemia resulting in tachycardia, change in mental status, cardiac ischemia, or SOB Transfusion 1996; 36:144. See Transfusion guidelines.
Packed RBCs  
•  Hemorrhage
•  Active Physiologic instability, including tachycardia, ↓ in systolic BP > 30 mm Hg below baseline, orthostatic hypotension, angina, mental confusion, agitation
•  Chronic Physiologic instability–see above, refractory state.
•  Sickle cell anemia
Refractory crisis, acute lung syndrome, CVA, priapism, hepatic infarct, acute papillary necrosis, general anesthesia, contrast studies
Platelets  
• Platelet count < 30,000/µL
•  Functional platelet deficit
•  Surgical prophylaxis
•  Massive bleeding
Cryoprecipitate  
•  Active bleeding, fibrinogen < 100 mg/dL
•  Massive bleeding
•  DIC w/ bleeding
•  10 fibrinolysis
Dysfibrinogenemia
Majorin fibrinogen, factor VIII, von Willebrand factor
± in reversible liver disease
Queens Hospital Medical Center, 1990
References in periodicals archive ?
If a dog presents with active bleeding already then a Vitamin K injection may be given immediately with the pills for long-term relief.
Patients with active bleeding or who are allergic to Clopidogrel or any component of the formulation may experience more serious adverse health consequences as a result of unknowingly consuming Clopidogrel.
During the first dialysis treatment, there was active bleeding at the fistula site, but a nurse did not inform the physician.
We confirmed the diagnosis of large intraprostatic hematoma with active bleeding post-TRUS-guided biopsy of the prostate.
No active bleeding was noted at any of the four biopsy sites.
For the majority of patients these methods should control even active bleeding 80--90% of the time.
An urgent epigastric and gastroduodenal angiogram did not reveal any evidence of active bleeding.
In our report, we describe the use of CEUS for assessment of the liver perfusion and for exclusion of active bleeding after transcutaneous liver biopsy.
Also it could be a diagnostic challenge even to an expert in GI endoscopy to diagnose this condition unless there is active bleeding from the papilla at the time of endoscopy.
Vitamin K deficiency (with or without warfarin effect) in the presence of active bleeding accounted for 20% of cases (Fig.
1] IV bolus injection, and then the same dose every 3 h for 1 d) was administered; active bleeding was controlled after 2 d of the treatment.